370 related articles for article (PubMed ID: 15248927)
1. [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study].
Zhou ZW; Wan DS; Wang GQ; Pan ZZ; Lu HP; Gao JH; Ding PR
Ai Zheng; 2004 Jul; 23(7):851-4. PubMed ID: 15248927
[TBL] [Abstract][Full Text] [Related]
2. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone receptors in gastric and colorectal cancer.
Oshima CT; Wonraht DR; Catarino RM; Mattos D; Forones NM
Hepatogastroenterology; 1999; 46(30):3155-8. PubMed ID: 10626177
[TBL] [Abstract][Full Text] [Related]
4. Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs.
Donnay I; Rauïs J; Devleeschouwer N; Wouters-Ballman P; Leclercq G; Verstegen J
Am J Vet Res; 1995 Sep; 56(9):1188-94. PubMed ID: 7486397
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
6. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
7. Relationship between hormone receptor levels and cell-kinetics in human colorectal cancer.
Korenaga D; Orita H; Maekawa S; Itasaka H; Ikeda T; Sugimachi K
Hepatogastroenterology; 1997; 44(13):78-83. PubMed ID: 9058124
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and progesterone receptors in the normal female breast.
Ricketts D; Turnbull L; Ryall G; Bakhshi R; Rawson NS; Gazet JC; Nolan C; Coombes RC
Cancer Res; 1991 Apr; 51(7):1817-22. PubMed ID: 2004366
[TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer.
Kansakar E; Chang YJ; Mehrabi M; Mittal V
Am Surg; 2009 Sep; 75(9):785-9; discussion 789. PubMed ID: 19774949
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
12. [Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma].
Shen K; Yueng W; Ngan H
Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):284-8, 317-8. PubMed ID: 7956553
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma.
Shen K; Yueng W; Ngan H
Chin Med J (Engl); 1994 Sep; 107(9):648-52. PubMed ID: 7805454
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
15. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
16. [Estrogen and progesterone receptors in endometrial carcinoma].
Guo Y; Dang Q
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
[TBL] [Abstract][Full Text] [Related]
17. Sex steroid receptor concentration in breast carcinoma tissue: effect of devascularization during mastectomy.
Leight GS; Wells SA; McCarty KS
Surgery; 1984 Mar; 95(3):256-60. PubMed ID: 6701781
[TBL] [Abstract][Full Text] [Related]
18. [Determination of estrogen receptor and progesterone receptor of the sinonasal malignant neoplasms].
Li T; Qiu Q; Wu N
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(2):100-2. PubMed ID: 9387503
[TBL] [Abstract][Full Text] [Related]
19. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
20. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.
Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Christiaens MR; Vergote I
Breast Cancer Res Treat; 2005 May; 91(1):81-7. PubMed ID: 15868434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]